ADAURA Trial: Adjuvant Osimertinib and Clinical Implications
ADAURA Trial: Adjuvant Osimertinib and Clinical Implications
Jul 17, 2023
onclive.com
The ADAURA Trial of Adjuvant Osimertinib in NSCLC
The ADAURA Trial of Adjuvant Osimertinib in NSCLC
Jun 17, 2021
onclive.com
ADAURA: Osimertinib as Adjuvant Therapy in Stage III EGFR NSCLC
ADAURA: Osimertinib as Adjuvant Therapy in Stage III EGFR NSCLC
Jul 13, 2020
onclive.com
WCLC 2023 Insights: "Osimertinib in Resected EGFRm NSCLC - ADAURA Trial"
WCLC 2023 Insights: "Osimertinib in Resected EGFRm NSCLC - ADAU…
80 viewsSep 23, 2023
vumedi.com
Dr Santos on the ADAURA Trial of Adjuvant Osimertinib in EGFR-Mutant NSCLC
Dr Santos on the ADAURA Trial of Adjuvant Osimertinib in EGFR-Mut…
Aug 17, 2023
onclive.com
Dr. Patil on ADAURA Data with Osimertinib in NSCLC
Dr. Patil on ADAURA Data with Osimertinib in NSCLC
Sep 2, 2021
onclive.com
Controversies Around ADAURA Trial on Adjuvant Osimertinib in EGFR Early Stage NSCLC
Controversies Around ADAURA Trial on Adjuvant Osimertinib in E…
2.9K viewsJul 8, 2020
vumedi.com
Adjuvant Osimertinib in Early-Stage NSCLC: The ADAURA Trial
Jul 19, 2022
onclive.com
ESMO 2022 Updated Results From ADAURA: Osimertinib as Adjuvan…
652 viewsDec 3, 2022
vumedi.com
ASCO® 2023 Insights: "ADAURA Trial - OS With Osimertinib for Pati…
93 viewsJul 22, 2023
vumedi.com
The ADAURA Trial: Adjuvant Osimertinib in EGFR Resectable N…
Jan 17, 2022
onclive.com
ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analy…
432 viewsJun 20, 2023
vumedi.com
Dr. Arnaoutakis on the ADAURA Trial Examining Osimertinib in EG…
Dec 8, 2021
onclive.com
Expert Discussion on 2020 ASCO Update on EGFRm NSCLC: How D…
334 viewsDec 27, 2020
vumedi.com
NSCLC: ADAURA Trial Results
Jul 1, 2021
onclive.com
Rapid Readouts: Patient-Reported Outcomes from ADAURA
Feb 19, 2021
onclive.com
13:00
Amivantamab Lazertinib Versus Osimertinib as 1L Treatment in EG…
Nov 10, 2023
onclive.com
Rapid Readouts: Postoperative Chemotherapy Use and Outcome…
Feb 19, 2021
onclive.com
Clinical Implications of the ADAURA Trial
Jun 17, 2021
onclive.com
Dr. Tsuboi on Findings From the Phase 3 ADAURA Trial in EGFR N…
Nov 20, 2020
onclive.com
Dr Herbst on Adjuvant Osimertinib in EGFR-mutant NSCLC
Jun 4, 2023
onclive.com
ESMO 2023 Insights: "RAMOSE Trial - Osimertinib /-Ramucirumab in T…
229 viewsNov 8, 2023
vumedi.com
Dr Schneider on Treatment Considerations After Osimertinib i…
Apr 5, 2024
onclive.com
ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Impl…
2.3K viewsJun 21, 2023
vumedi.com
Adjuvant Therapy for EGFR Mutant Early-Stage NSCLC: ADAURA
Dec 20, 2021
onclive.com
Dr Cummings on the Investigation of Osimertinib in EGFR-Mutant NS…
Mar 22, 2023
onclive.com
Dr. Herbst on the Approval of Adjuvant Osimertinib in EGFR NS…
Jan 6, 2021
onclive.com
2020 ESMO Updates on Advanced NSCLC: Adjuvant Osimertinib for …
110 viewsJul 12, 2023
vumedi.com
Osimertinib Poised to Change Standard of Care Treatment for Pa…
10 months ago
reachmd.com
ESMO 2024 Insights: Acquired Resistance to 1L Amivantamab La…
121 views6 months ago
vumedi.com
See more videos
Static thumbnail place holder